These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6767187)

  • 61. How I manage patients with Wiskott Aldrich syndrome.
    Rivers E; Worth A; Thrasher AJ; Burns SO
    Br J Haematol; 2019 May; 185(4):647-655. PubMed ID: 30864154
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Wiscott Aldrich syndrome with oral involvement: a case report.
    Reddy SS; Binnal A
    J Dent Child (Chic); 2011; 78(1):49-52. PubMed ID: 22041009
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Congenital cytomegalovirus infection and Wiskott-Aldrich syndrome successfully treated with unrelated cord blood transplantation.
    Almagor Y; Revel-Vilk S; Averbuch D; Mechoulam H; Engelhard D; Resnick IB; Weintraub M; Stepensky P
    Pediatr Blood Cancer; 2011 Oct; 57(4):681-3. PubMed ID: 21618408
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Platelet defect in Wiskott-Aldrich syndrome.
    Baldini MG
    N Engl J Med; 1969 Jul; 281(2):107. PubMed ID: 5784770
    [No Abstract]   [Full Text] [Related]  

  • 65. Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation.
    Shah AJ; Sokolic R; Logan B; Yin Z; Iyengar S; Scalchunes C; Mangurian C; Albert M; Cowan MJ
    J Clin Immunol; 2019 Nov; 39(8):786-794. PubMed ID: 31620947
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunologic studies before and after splenectomy in a patient with the Wiskott-Aldrich syndrome.
    Knutsen AP; Rosse WF; Kinney TR; Buckley RH
    J Clin Immunol; 1981 Jan; 1(1):13-9. PubMed ID: 7334067
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Platelet size and kinetics in hereditary and acquired thrombocytopenia.
    Murphy S; Oski FA; Naiman JL; Lusch CJ; Goldberg S; Gardner FH
    N Engl J Med; 1972 Mar; 286(10):499-504. PubMed ID: 5062078
    [No Abstract]   [Full Text] [Related]  

  • 68. Successful Long-term Graft Survival of a Renal Transplantation Patient with Wiskott-Aldrich Syndrome.
    Kai K; Sumida M; Motoyoshi Y; Ogawa Y; Miki K; Iwadoh K; Sannomiya A; Murakami T; Koyama I; Kitajima K; Nakajima I; Morio T; Fuchinoue S
    Intern Med; 2016; 55(13):1761-3. PubMed ID: 27374679
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Wiskott Aldrich syndrome: an immunodeficiency syndrome not rare in Western Australia.
    Somerville C; Forsyth KD
    Pediatr Allergy Immunol; 1993 May; 4(2):65-72. PubMed ID: 8353648
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Urgent minimal invasive treatment of a dental trauma in a child with Wiskott-Aldrich syndrome.
    Salazar SL; Soares TR; Maia LC
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):573-5. PubMed ID: 23358227
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Early bone marrow transplantation in an infant with Wiskott-Aldrich syndrome.
    Beard LJ; Toogood IR; Pearson CC; Ferrante A
    Am J Pediatr Hematol Oncol; 1991; 13(3):310-4. PubMed ID: 1793157
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Wiskott-Aldrich syndrome: molecular pieces slide into place.
    Kuska B
    J Natl Cancer Inst; 2000 Jan; 92(1):9-11. PubMed ID: 10620622
    [No Abstract]   [Full Text] [Related]  

  • 73. [Metabolic defect of thrombocytopenic thrombocytopathia in the Wiskott-Aldrich syndrome (author's transl)].
    Kuramoto A
    Nihon Ketsueki Gakkai Zasshi; 1975 Dec; 38(6):786-92. PubMed ID: 1243804
    [No Abstract]   [Full Text] [Related]  

  • 74. Long-term treatment of refractory thrombocytopenia in a patient with Wiskott-Aldrich syndrome with vincristine, immunoglobulin, and methylprednisolone.
    Young G; Angiolillo AL
    Am J Hematol; 1999 Nov; 62(3):183-5. PubMed ID: 10539885
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Shimizu M; Kanegane H; Wada T; Motoyoshi Y; Morio T; Candotti F; Yachie A
    J Allergy Clin Immunol; 2013 Feb; 131(2):587-90.e1-3. PubMed ID: 23107152
    [No Abstract]   [Full Text] [Related]  

  • 76. Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Crestani E; Volpi S; Candotti F; Giliani S; Notarangelo LD; Chu J; Aldave Becerra JC; Buchbinder D; Chou J; Geha RS; Kanariou M; King A; Mazza C; Moratto D; Sokolic R; Garabedian E; Porta F; Putti MC; Wakim RH; Tsitsikov E; Pai SY; Notarangelo LD
    J Allergy Clin Immunol; 2015 Nov; 136(5):1401-4.e1-3. PubMed ID: 26409660
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical features of Wiskott-Aldrich syndrome: an analysis of 13 cases].
    Liu C; Chen XY; Wu WQ; An WB; Chang LX; Lan Y; Yi MH; Cai YL; Feng J; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 May; 21(5):463-467. PubMed ID: 31104664
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Wiskott-Aldrich syndrome].
    Román Jiménez MG; Yamazaki Nakashimada MA; Blancas Galicia L
    Rev Alerg Mex; 2010; 57(5):171-5. PubMed ID: 21854728
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical Features and Outcomes of 23 Patients with Wiskott-Aldrich Syndrome: A Single-Center Experience.
    Haskoloğlu Ş; Öztürk A; Öztürk G; Kostel Bal S; İslamoğlu C; Baskın K; Ceylaner S; Tufan Satıroğlu L; Doğu F; İkincioğulları A
    Turk J Haematol; 2020 Nov; 37(4):271-281. PubMed ID: 32812413
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome.
    Jyonouchi S; Gwafila B; Gwalani LA; Ahmad M; Moertel C; Holbert C; Kim JY; Kobrinsky N; Roy-Ghanta S; Orange JS
    Clin Immunol; 2017 Jun; 179():47-53. PubMed ID: 28232030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.